HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jan E Dyr Selected Research
Jan E Dyr Research Topics
Disease
15
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 01/2012
5
Cytopenia
01/2015 - 10/2011
4
Thrombosis (Thrombus)
03/2022 - 09/2009
4
Refractory Anemia
01/2015 - 05/2012
2
Inflammation (Inflammations)
05/2020 - 02/2011
2
Cardiovascular Diseases (Cardiovascular Disease)
02/2015 - 06/2011
2
Rare Diseases (Rare Disease)
10/2014 - 09/2009
2
Congenital Dysfibrinogenemia
10/2014 - 09/2009
2
Hemorrhage
01/2013 - 01/2007
1
Infarction (Infarctions)
03/2022
1
Atherosclerosis
05/2020
1
Neoplasms (Cancer)
11/2019
1
Heart Diseases (Heart Disease)
11/2019
1
Neurodegenerative Diseases (Neurodegenerative Disease)
11/2019
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1
Afibrinogenemia (Fibrinogen Deficiency)
10/2013
1
Stable Angina
06/2011
1
Myocardial Infarction
06/2011
1
Unstable Angina
06/2011
Drug/Important Bio-Agent (IBA)
6
Proteome
IBA
01/2015 - 06/2011
5
Proteins (Proteins, Gene)
FDA Link
11/2019 - 01/2012
5
Fibrinogen (Factor I)
FDA Link
10/2014 - 01/2007
4
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2015
3
Fibrin
IBA
03/2022 - 02/2011
2
Leucine (L-Leucine)
FDA Link
01/2022 - 05/2012
2
MicroRNAs (MicroRNA)
IBA
01/2018 - 08/2015
2
Apolipoprotein A-I (Apolipoprotein A1)
IBA
02/2015 - 06/2011
2
Blood Proteins (Serum Proteins)
IBA
01/2015 - 05/2012
2
inter-alpha-inhibitor
IBA
04/2013 - 05/2012
1
Riboflavin (Vitamin B2)
FDA Link
Generic
05/2020
1
Malondialdehyde (Propanedial)
IBA
05/2020
1
Tryptophan (L-Tryptophan)
FDA Link
05/2020
1
Neopterin
IBA
05/2020
1
Azacitidine (5 Azacytidine)
FDA Link
01/2018
1
alpha-2-HS-Glycoprotein
IBA
12/2017
1
Disulfides
IBA
11/2015
1
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
08/2013
1
Retinol-Binding Proteins (Retinoid Binding Proteins)
IBA
04/2013
1
Peptides (Polypeptides)
IBA
04/2013
1
Protein Isoforms (Isoforms)
IBA
06/2011
Therapy/Procedure
2
Therapeutics
03/2022 - 01/2018